相关实验视频
Updated: May 10, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.5K
阻断PSMD14介导的E2F1/ERK/AKT信号通路可以抑制类甲状腺癌的进展
Yuxuan Wang1, Yuansheng Duan1, Kai Yue1
1Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, Tianjin 300060, China.
Cellular signalling
|April 22, 2025
概括
无塑性甲状腺癌 (ATC) 细胞依赖PSMD14进行生长和入侵. 用硫素抑制PSMD14可以阻止ATC的进展,并为这种侵袭性癌症提供潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 无塑性甲状腺癌 (ATC) 是高度侵略性的,治疗选择有限.
- 双化酶PSMD14是各种癌症的潜在治疗标,但其在ATC中的作用尚不清楚.
研究的目的:
- 为了研究PSMD14在甲状腺癌的作用.
- 评估PSMD14作为ATC的潜在治疗点.
主要方法:
- 在ATC组织中分析PSMD14表达.
- 在体外研究涉及PSMD14在ATC细胞中用硫素 (THL) 减少或抑制PSMD14.
- 使用ATC异种移植的体内研究.
- 关于E2F1稳定和下游信号通路 (ERK,AKT) 的机制研究.
主要成果:
- PSMD14在ATC上升调节,并与患者的生存率差相关.
- PSMD14促进ATC细胞的增殖,入侵和上皮细胞-介质细胞过渡 (EMT).
- 减少PSMD14或治疗THL可以抑制ATC的生长,侵入,诱导细胞循环停止和细胞亡.
- 在体内,THL对ATC异种移植有强烈的抑制作用.
- PSMD14稳定了E2F1,激活了对ATC至关重要的ERK和AKT通路.
结论:
- PSMD14在形甲状腺癌中起着显著的致癌作用.
- 针对PSMD14,例如用硫素,代表了ATC的一个有前途的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K

